Working Together to Address Global Drug Safety Issues with Packaging and Labeling
Join the Institute for Safe Medication Practices for a complimentary webinar that seeks to inspire and mobilize drug manufacturers and regulators from around the world to focus on reducing medication errors. Learn about product issues that contribute to medication errors globally during this FREE webinar.
Many of the product container labeling and packaging issues are common across the world. To achieve a reduction of overall harm related to medication errors, industry and regulator response at the global level is desired. Also, in many countries and regions throughout the world, domestic drug manufacturing does not exist, so drugs are commonly imported, often with features that can result in safety issues.
Our speaker will provide an update on successful packaging and labeling changes that have been undertaken in some countries to reduce the risk of errors. Highlights from a recent international summit on drug labeling and packaging held by global regulators and the International Medication Safety Network will be described.
- Pharmaceutical Manufacturers
- Drug Product Regulators
- Hospital and Health System Leadership
- Quality and Risk Management Leaders
- Physician, Pharmacy, and Nursing Leaders
- Medication Safety and Patient Safety Officers
Following completion of this activity, participants will be able to:
- Identify the most common unsafe drug product labeling and packaging issues around the globe.
- Promote the use of safety technologies and ready-to-use products such as unit dose products, prefilled syringes and premixed IV solutions to reduce medication errors.
- Describe the anticipated challenges to global harmonization of medication practices that impact labeling and packaging.
- Understand the role of the pharmacovigilance community and error reporting programs.
- Recognize the role of drug regulators, pharmaceutical industries and practitioners to improve medication error reporting.
Introduction and Overview:
Michael R. Cohen, RPh, MS, ScD (hon.), DPS (hon.), FASHP, President, ISMP
This activity is funded through an educational grant from Novartis.
No continuing education credits are available for this activity.